BioSante Pharmaceuticals, Inc. (BPAX)

[dgras0007]

This is the way I see it: First this is a Nasdaq company traded stock at over 2.60 until 2 weeks ago. Although the news were not interepreted as great - it still left room for additional clarification which could make the case (remember SOMX? going down to 0.90 cents on misinterpreted news only to shoot to the 4's in no time and then to 10 after FDA approval )- could be the same case and that is just with the "apparent failed drug". But another drug - the one going for February can take the stock right back to the 2's on the runup and if approved probably 4-6 dolalr range. The other effect is that this company is not facing dilution as they had just raised money on October so no need to dilute. Plus the short squeeze. In my view the calls have a huge potential ranging all the way to 4-6 bucks after feb 14 PDUFA date. That meanas that the gains could be in the range of 3000 -5000% your money. So if you invested 1K in the calls it could be worth 20k...